Systemic Delivery of Synthetic MicroRNA-16 Inhibits the Growth of Metastatic Prostate Tumors via Downregulation of Multiple Cell-cycle Genes-Reference-Cited by-同舟云学术

Systemic Delivery of Synthetic MicroRNA-16 Inhibits the Growth of Metastatic Prostate Tumors via Downregulation of Multiple Cell-cycle Genes

Published:2010-01 Issue:1 Volume:18 Page:181-187
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Takeshita Fumitaka,Patrawala Lubna,Osaki Mitsuhiko,Takahashi Ryou-u,Yamamoto Yusuke,Kosaka Nobuyoshi,Kawamata Masaki,Kelnar Kevin,Bader Andreas G.,Brown David,Ochiya Takahiro

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference30 articles.

1. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers;Calin;Proc Natl Acad Sci USA,2004

2. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia;Calin;N Engl J Med,2005

3. MicroRNA-cancer connection: the beginning of a new tale;Calin;Cancer Res,2006

4. MicroRNA expression profiles classify human cancers;Lu;Nature,2005

5. A microRNA expression signature of human solid tumors defines cancer gene targets;Volinia;Proc Natl Acad Sci USA,2006

Cited by 375 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological Barriers for Drug Delivery and Development of Innovative Therapeutic Approaches in HIV, Pancreatic Cancer, and Hemophilia A/B;Pharmaceutics;2024-09-13

2. Nanomaterials for bone metastasis;Journal of Controlled Release;2024-09

3. The Delivery of Mimic miRNA-7 into Glioblastoma Cells and Tumour Tissue by Graphene Oxide Nanosystems;Nanotechnology, Science and Applications;2024-09

4. MicroRNAs and proteolytic cleavage of receptors in cancers: A comprehensive review of regulatory interactions and therapeutic implications;Heliyon;2024-04

5. The regulatory process and practical significance of non-coding RNA in the dissemination of prostate cancer to the skeletal system;Frontiers in Oncology;2024-03-21